These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15024828)

  • 21. Wechsler Adult Intelligence Scale-III profile in the early stages of Alzheimer's disease: performance in subtests sensitive to and resistant to normal decline with ageing.
    Matsuda O; Saito M; Kato M; Azami H; Shido E
    Psychogeriatrics; 2015 Mar; 15(1):1-6. PubMed ID: 25515267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
    Sato N; Ueki A; Ueno H; Shinjo H; Morita Y
    J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
    Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
    Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of donepezil at six months in the treatment of cognition deterioration in patients with Alzheimer-type dementia].
    López-Pousa S; Vilalta-Franch J; Garre-Olmo J; Turón-Estrada A; Hernández-Ferrándiz M; Cruz-Reina ML
    Rev Neurol; 2000 Oct 16-31; 31(8):724-8. PubMed ID: 11082878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Chiloiro R; Dellegrazie F; Di Palo A; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2010 Feb; 58(2):389-90. PubMed ID: 20370868
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease.
    Gauthier S; Lopez OL; Waldemar G; Jones RW; Cummings J; Zhang R; Schindler R; Schwam E
    Int Psychogeriatr; 2010 Sep; 22(6):973-83. PubMed ID: 20534179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: implications for early diagnosis and treatment.
    Molinuevo JL; Berthier ML; Rami L
    Arch Gerontol Geriatr; 2011; 52(1):18-22. PubMed ID: 19948364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donepezil Improved Cognitive Deficits in a Patient With Neurosyphilis.
    Wu YS; Lane HY; Lin CH
    Clin Neuropharmacol; 2015; 38(4):156-7. PubMed ID: 26166240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of a seven-subtest version of the WAIS-R among an Alzheimer's disease sample.
    Schopp LH; Callahan CD; Johnstone B; Schwake CJ
    Arch Clin Neuropsychol; 1998 Oct; 13(7):637-43. PubMed ID: 14590625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study.
    Rapp M; Burkart M; Kohlmann T; Bohlken J
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):130-133. PubMed ID: 29319499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular pharmacodynamics of donepezil hydrochloride on the PR and QT intervals in patients with dementia.
    Igeta H; Suzuki Y; Tajiri M; Someya T
    Hum Psychopharmacol; 2014 May; 29(3):292-4. PubMed ID: 24615803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's drug helps brain function after radiotherapy.
    McCaffrey P
    Lancet Oncol; 2006 May; 7(5):371. PubMed ID: 16696167
    [No Abstract]   [Full Text] [Related]  

  • 38. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
    Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
    Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
    Passmore AP; Bayer AJ; Steinhagen-Thiessen E
    J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease.
    Doody RS; Dunn JK; Clark CM; Farlow M; Foster NL; Liao T; Gonzales N; Lai E; Massman P
    Dement Geriatr Cogn Disord; 2001; 12(4):295-300. PubMed ID: 11351141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.